GU Yubiao, FENG Hui, ZHENG Lin, et al. Effects of Jiawei Xuefu Zhuyu Decoction(加味血府逐瘀汤) Combined with Rivaroxaban on Deep Venous Thrombosis after Total Knee Replacement Patients[J]. Journal of Traditional Chinese Medicine2018, 59(18): 1578-1582.
GU Yubiao, FENG Hui, ZHENG Lin, et al. Effects of Jiawei Xuefu Zhuyu Decoction(加味血府逐瘀汤) Combined with Rivaroxaban on Deep Venous Thrombosis after Total Knee Replacement Patients[J]. Journal of Traditional Chinese Medicine2018, 59(18): 1578-1582.DOI: 10.13288/j.11-2166/r.2018.18.011.
Effects of Jiawei Xuefu Zhuyu Decoction(加味血府逐瘀汤) Combined with Rivaroxaban on Deep Venous Thrombosis after Total Knee Replacement Patients
Objective To evaluate the clinical efficacy of Jiawei Xuefu Zhuyu Decoction( 加味血府逐瘀汤) combined with rivaroxaban in preventing deep venous thrombosis( DVT) after total knee replacement( TKA) of patients with knee osteoarthritis. Methods A total of 105 patients were randomly divided into Chinese medicine group( 35 patients)
western medicine group( 35 patients) and integrated Chinese and western medicine group( 35 patients).All patients in each group accepted pain and rehabilitation management and anti-infective therapy after the surgery.Jiawei Xuefu Zhuyu Decoction by oral administration was given to Chinese medicine group at the 1 st day after the surgery
10 mg rivaroxaban by oral administration to western medicine group
once every night. Jiawei Xuefu Zhuyu Decoction combined with rivaroxaban by oral administration was given to integrated Chinese and western medicine group. All groups were treated for 14 days continuously. The condition of DVT
plasma D-dimer
VAS score
range of movement( ROM) and traditional Chinese medicine( TCM) syndrome score were observed before the surgery and on the 3 rd
7 th
14 th day after the surgery. And the postoperative wound healing and complications were observed.Results The level of plasma D-dimer in three groups on the 3 rd
7 th
14 th day after the surgery were all significantly higher than before the surgery( P < 0. 05)
and D-dimer level of the integrated Chinese and western medicine group on the 3 rd day after the surgery was significantly lower than that of the other 2 groups( P < 0. 05). VAS score in each group on the 3 rd
7 th
14 th day after the surgery were all lower than before the surgery( P < 0. 05) and the score of integrated Chinese and western medicine group in 14 days after the surgery was obviously lower than that of the other groups( P < 0. 05). After surgery the TCM syndrome scores in all groups were significantly lower than those before the surgery( P < 0. 05)
and the score in integrated Chinese and western medicine group was significantly lower than Chinese medicine group and western medicine group in 14 days after the surgery( P < 0. 05). The ROM score in 14 days after the surgery in all groups were significantly higher than that before the surgery( P < 0. 05). The swelling rate of the integrated Chinese and western medicine group was lower than that of the Chinese medicine group and western medicine group in 14 days after the surgery
and the rate of integrated Chinese and western medicine group was lower than that of the western medicine group( P < 0. 05). Conclusion The combination of Jiawei Xuefu Zhuyu Decoction and rivaroxaban is effective in preventing DVT
WANG Qingguo's Experience in Treatment of Headache Based on the Concept of "Achieving Harmony by Unblocking and Balancing"
Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases:A Multicenter,Retrospective Real-World Cohort Study
Effect of Xiaoqinglong Decoction (小青龙汤) on Th2 Immune Responses and Nasal Mucosal TSLP/OX40L Pathway in Allergic Rhinitis Model Rats
Exploring the Comorbidity Mechanism,Prevention and Treatment Strategies of Rheumatoid Arthritis with Coronary Atherosclerotic Heart Disease Based on Collateral Disease Theory
Current Status and Strategic Recommendations for Randomized Controlled Trials on Functional Dyspepsia-Irritable Bowel Syndrome Comorbidity:from a Real-World Research Perspective